Ortizo, Baby Girl .
HRN: 23-96-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/31/2023
11/07/2023
IVT
44mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes